Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astrana Health Q2 EPS $0.19 Misses $0.35 Estimate, Sales $654.800M Beat $637.774M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:11pm
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.35 by 45.4 percent. This is a 52.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $654.800 million which beat the analyst consensus estimate of $637.774 million by 2.67 percent. This is a 34.66 percent increase over sales of $486.265 million the same period last year.

Posted In: ASTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist